Skip to main content
NVDA-2.45%AAPL+3.15%GOOGL+0.49%MSFT-0.06%AMZN-0.09%TSM-1.31%SPCX+0.86%AVGO-0.59%META-1.13%TSLA-0.39%SKHY-4.03%MU-4.35%BRK-B-0.24%LLY-0.02%JPM-0.67%WMT-0.13%AMD-3.08%V-0.21%XOM+0.53%ASMLa-1.66%JNJ-0.13%INTC-4.54%MA-0.58%0700.HK-1.94%1398.HK+0.79%ORCL-3.89%ABBV+0.98%BAC-0.53%CSCO-1.08%CVX-0.49%COST-0.18%KO+0.60%LRCX-4.97%CAT-1.40%AP2d-1.55%0005.HK-0.78%AMAT-2.55%UNH-0.99%HSBA.L-1.30%DELL-3.48%PG+0.50%MS-1.08%GE-0.68%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.18%HD-1.79%0939.HK+1.66%GS-1.13%NZDJPY-2.62%AUDJPY-1.82%CHFJPY-1.61%NZDCAD-1.47%EURNZD+1.45%NZDUSD-1.42%GBPNZD+1.39%GBPJPY-1.24%USDJPY-1.24%EURJPY-1.23%CADJPY-1.17%NZDCHF-1.05%USDZAR+0.98%USDNOK+0.90%USDSEK+0.86%AUDNZD+0.84%EURZAR+0.82%GBPZAR+0.74%EURNOK+0.74%EURSEK+0.70%AUDCAD-0.68%USDTHB+0.63%AUDDKK-0.63%EURAUD+0.60%AUDUSD-0.59%CHFNOK+0.57%GBPAUD+0.56%CHFSEK+0.53%AUDSGD-0.53%USDMXN+0.49%NZDSGD-0.43%CADCHF+0.42%USDPLN+0.42%GBPTRY+0.41%NOKJPY-0.40%USDCHF+0.38%EURCHF+0.38%GBPCHF+0.35%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.26%EURPLN+0.26%SGDJPY+0.24%NZDMXN-0.22%AUDCHF-0.21%EURHKD-0.17%USDDKK+0.16%USDILS+0.16%USDTRY+0.11%AUDNOK+0.11%EURSGD+0.10%USDCNH+0.10%GBPCAD-0.09%PLNJPY+0.08%CHFSGD-0.06%EURCAD-0.06%USDCAD-0.05%EURCZK-0.05%EURCNH-0.04%EURGBP+0.04%USDCOP-0.04%USDHKD+0.02%GBPSGD+0.01%GBPUSD-0.01%EURUSD+0.01%EURDKK0.00%XPTUSD-5.92%GAGUSD-5.01%XAGUSD-5.01%HG1-4.81%UKOIL+4.71%USOIL+4.53%XNGUSD+1.66%XAUUSD-1.56%GAUUSD-1.56%COTTON0.00%SUGAR0.00%W10.00%BTCUSD-1.33%ETHUSD-0.06%USDTUSD-0.04%XRPUSD-2.89%SOLUSD-1.66%TRXUSDT+0.24%ZECUSDT-8.33%DOGEUSD-2.54%XMRUSDT+0.39%LINKUSD-1.12%XLMUSD-1.19%BCHUSDT-9.71%LTCUSD-1.41%UNIUSD-0.88%TONUSD+24.88%HBARUSDT-2.25%SUIUSD-3.92%TAOUSDT-5.10%AAVEUSD-2.12%DOTUSDT-1.47%ICPUSDT-0.72%ONDOUSDT-3.01%WLDUSDT-2.67%ATOMUSDT-2.87%ARBUSDT+0.42%JUPUSDT-3.39%INJUSDT-2.26%STXUSDT-4.16%FETUSDT-2.62%TIAUSDT-0.34%PYTHUSDT-1.09%SEIUSDT-6.02%IMXUSDT-3.06%GRTUSDT-3.02%WIFUSDT-4.89%OPUSDT-3.00%POLUSDT-4.36%IOTAUSDT-3.35%AXSUSDT-2.14%FARTCOINUSDT-3.28%EOSUSDT-2.41%DYDXUSDT-1.84%ORDIUSDT-0.34%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.45%AAPL+3.15%GOOGL+0.49%MSFT-0.06%AMZN-0.09%TSM-1.31%SPCX+0.86%AVGO-0.59%META-1.13%TSLA-0.39%SKHY-4.03%MU-4.35%BRK-B-0.24%LLY-0.02%JPM-0.67%WMT-0.13%AMD-3.08%V-0.21%XOM+0.53%ASMLa-1.66%JNJ-0.13%INTC-4.54%MA-0.58%0700.HK-1.94%1398.HK+0.79%ORCL-3.89%ABBV+0.98%BAC-0.53%CSCO-1.08%CVX-0.49%COST-0.18%KO+0.60%LRCX-4.97%CAT-1.40%AP2d-1.55%0005.HK-0.78%AMAT-2.55%UNH-0.99%HSBA.L-1.30%DELL-3.48%PG+0.50%MS-1.08%GE-0.68%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.18%HD-1.79%0939.HK+1.66%GS-1.13%NZDJPY-2.62%AUDJPY-1.82%CHFJPY-1.61%NZDCAD-1.47%EURNZD+1.45%NZDUSD-1.42%GBPNZD+1.39%GBPJPY-1.24%USDJPY-1.24%EURJPY-1.23%CADJPY-1.17%NZDCHF-1.05%USDZAR+0.98%USDNOK+0.90%USDSEK+0.86%AUDNZD+0.84%EURZAR+0.82%GBPZAR+0.74%EURNOK+0.74%EURSEK+0.70%AUDCAD-0.68%USDTHB+0.63%AUDDKK-0.63%EURAUD+0.60%AUDUSD-0.59%CHFNOK+0.57%GBPAUD+0.56%CHFSEK+0.53%AUDSGD-0.53%USDMXN+0.49%NZDSGD-0.43%CADCHF+0.42%USDPLN+0.42%GBPTRY+0.41%NOKJPY-0.40%USDCHF+0.38%EURCHF+0.38%GBPCHF+0.35%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.26%EURPLN+0.26%SGDJPY+0.24%NZDMXN-0.22%AUDCHF-0.21%EURHKD-0.17%USDDKK+0.16%USDILS+0.16%USDTRY+0.11%AUDNOK+0.11%EURSGD+0.10%USDCNH+0.10%GBPCAD-0.09%PLNJPY+0.08%CHFSGD-0.06%EURCAD-0.06%USDCAD-0.05%EURCZK-0.05%EURCNH-0.04%EURGBP+0.04%USDCOP-0.04%USDHKD+0.02%GBPSGD+0.01%GBPUSD-0.01%EURUSD+0.01%EURDKK0.00%XPTUSD-5.92%GAGUSD-5.01%XAGUSD-5.01%HG1-4.81%UKOIL+4.71%USOIL+4.53%XNGUSD+1.66%XAUUSD-1.56%GAUUSD-1.56%COTTON0.00%SUGAR0.00%W10.00%BTCUSD-1.33%ETHUSD-0.06%USDTUSD-0.04%XRPUSD-2.89%SOLUSD-1.66%TRXUSDT+0.24%ZECUSDT-8.33%DOGEUSD-2.54%XMRUSDT+0.39%LINKUSD-1.12%XLMUSD-1.19%BCHUSDT-9.71%LTCUSD-1.41%UNIUSD-0.88%TONUSD+24.88%HBARUSDT-2.25%SUIUSD-3.92%TAOUSDT-5.10%AAVEUSD-2.12%DOTUSDT-1.47%ICPUSDT-0.72%ONDOUSDT-3.01%WLDUSDT-2.67%ATOMUSDT-2.87%ARBUSDT+0.42%JUPUSDT-3.39%INJUSDT-2.26%STXUSDT-4.16%FETUSDT-2.62%TIAUSDT-0.34%PYTHUSDT-1.09%SEIUSDT-6.02%IMXUSDT-3.06%GRTUSDT-3.02%WIFUSDT-4.89%OPUSDT-3.00%POLUSDT-4.36%IOTAUSDT-3.35%AXSUSDT-2.14%FARTCOINUSDT-3.28%EOSUSDT-2.41%DYDXUSDT-1.84%ORDIUSDT-0.34%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%
AL

Aldeyra The (ALDX)

NASDAQ • Healthcare

$1.5
-$0.04 (-2.6%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$1.53
Previous Close$1.5
Day Range$1.5 - $1.54
Avg. Volume (3M)685.2K
Market Cap$89.2M
52 Week Range
$1.07$5.93
Next EarningsIn 55 daysNov 4, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$23M
EPS (TTM)
-$0.39
ROA (TTM)
-48.49%
Current Ratio
4.91

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+21.4%Q1 2026-$0.11
+53.8%Q2 2026-$0.06
-2.9%Q3 2026-$0.09
Next

Nov 4

in 55 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Aldeyra The

Aldeyra The is a small-cap biotechnology company listed on NASDAQ under ALDX that discovers and develops therapies for immune-mediated diseases. The pipeline centers on inflammation-focused drug candidates spanning late-stage, mid-stage, and preclinical programs, with work rooted in both RASP modulation and a dihydrofolate reductase inhibitor approach.

Name
Aldeyra The
CEO
Todd C. Brady
Website
www.aldeyra.com
Industry
Healthcare
Year Founded
2004
Employees
6

Today's Snapshot

AI-generated

ALDX is trading 0.7% lower at 1.49, while its sector was flat.

Trading Volume

Below 10d avg (481.1K)

214.9K

vs S&P 500 Today

Moderate Underperformance

-0.11%

Updated: September 10, 2026 at 16:32 UTC

Technical Indicators

0 Buy3 Neutral5 Sell
ALDX is a strong sell because the stock sits below its short- and medium-term moving averages and well under the 200-day average, reflecting clear price disadvantage while volume trends point to distribution. Momentum is weak to neutral — RSI in the low 40s and a modestly negative CCI accompany a small negative MACD — and the price is trading beneath the intraday VWAP. Trend strength is limited with ADX around 20, and volatility is muted with an ATR near $0.07, which has kept moves constrained. Technical takeaway: Strong sell — price below key moving averages with declining volume and weak momentum.
All signals
  • EMA (5 indicators)$1.50 - $2.98
    Sell
  • RSI (14)42.50
    Neutral
  • Stochastic %K (14, 3, 3)34.52
    Neutral
  • MACD Level (12, 26)-0.04
    Neutral

Peers & Related Assets

ANROAlto Neuroscience, Inc.
CADLCandel Therapeutics, Inc.
SLNSilence Therapeutics plc
CTNMContineum Therapeutics, Inc.
KYTXKyverna Therapeutics, Inc.
CLLSCellectis S.A.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.